Isabelle Hmitou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Isabelle Hmitou has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Alain Eychène
Institut Curie, Orsay, France
4 shared publications - Sabine Druillennec
Institut Curie, Orsay, France
4 shared publications - Matthieu Gérard
Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC)
3 shared publications Agathe Valluet
Institut Curie, Orsay, France
2 shared publicationsAmani Ouedrani
Clinical Investigation Center CIC1416 and Département de Biothérapie, Hôpital Necker, Assistance Publique des Hôpitaux de Paris, Paris, France
2 shared publicationsArnaud Depaux
Institute for Integrative Biology of the Cell (I2BC), IBITECS, CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette, France
2 shared publications
Latest Publications
- Open Access
- 1 June 2019
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 13, 303-309
Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
- 1 June 2019
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 13, 303-309
Open AccessSafety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
- 4 July 2017
- Published by Springer Nature
- Vol. 1622, 91-100
Efficient Depletion of Essential Gene Products for Loss-of-Function Studies in Embryonic Stem Cells
The development of the CRISPR/Cas9 technology has provided powerful methods to target genetic alterations. However, investigating the function of genes essential for cell survival remains problematic, because genetic ablation of these genes results in cell death. As a consequence, cells recombined at the targeted gene and fully depleted of the gene product cannot be obtained. RNA interference is well suited for the study of essential genes, but this approach often results in a partial depletion of the targeted gene product, which can lead to misinterpretations. We previously developed the pHYPER shRNA vector, a high efficiency RNA interference vector, which is based on a 2.5-kb mouse genomic fragment encompassing the H1 gene. We provide here a pHYPER-based protocol optimized to study the function of essential gene products in mouse embryonic stem cells.
- 4 July 2017
- Published by Springer Nature
- Vol. 1622, 91-100
Efficient Depletion of Essential Gene Products for Loss-of-Function Studies in Embryonic Stem Cells
The development of the CRISPR/Cas9 technology has provided powerful methods to target genetic alterations. However, investigating the function of genes essential for cell survival remains problematic, because genetic ablation of these genes results in cell death. As a consequence, cells recombined at the targeted gene and fully depleted of the gene product cannot be obtained. RNA interference is well suited for the study of essential genes, but this approach often results in a partial depletion of the targeted gene product, which can lead to misinterpretations. We previously developed the pHYPER shRNA vector, a high efficiency RNA interference vector, which is based on a 2.5-kb mouse genomic fragment encompassing the H1 gene. We provide here a pHYPER-based protocol optimized to study the function of essential gene products in mouse embryonic stem cells.
- 1 May 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (5) , 1641-1649.e6
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease
- 1 May 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (5) , 1641-1649.e6
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S88
225. Preserving CD4+ T-Cells Phenotype and Function Upon Ex Vivo Lentiviral Transduction
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S88
Open Access225. Preserving CD4+ T-Cells Phenotype and Function Upon Ex Vivo Lentiviral Transduction
- Open Access
- 27 January 2016
- Published by Springer Nature in Nature
- Vol. 530 (7588) , 113-116
Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells
Genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem (ES) cells are determined at single nucleosome resolution; each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller acts as a positive or negative regulator of transcription depending on the promoter chromatin organization and epigenetic marking of the gene it binds. The action of chromatin remodeling enzymes is required to allow transcription factors and the general transcription machinery access to DNA. Matthieu Gérard and colleagues determine genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem cells at single nucleosome resolution. They find that each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller can act as a positive or negative regulator of transcription depending on the activity of the gene it binds. The findings illustrate how remodellers work together at specific nucleosome positions adjacent to nucleosome-depleted promoter regions in order to regulate transcription. ATP-dependent chromatin remodellers allow access to DNA for transcription factors and the general transcription machinery, but whether mammalian chromatin remodellers1,2,3 target specific nucleosomes to regulate transcription is unclear. Here we present genome-wide remodeller–nucleosome interaction profiles for the chromatin remodellers Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind one or both full nucleosomes that flank micrococcal nuclease (MNase)-defined nucleosome-free promoter regions (NFRs), where they separate divergent transcription. Surprisingly, large CpG-rich NFRs that extend downstream of annotated transcriptional start sites are nevertheless bound by non-nucleosomal or subnucleosomal histone variants (H3.3 and H2A.Z) and marked by H3K4me3 and H3K27ac modifications. RNA polymerase II therefore navigates hundreds of base pairs of altered chromatin in the sense direction before encountering an MNase-resistant nucleosome at the 3′ end of the NFR. Transcriptome analysis after remodeller depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. Whereas at active genes individual remodellers have either positive or negative roles via altering nucleosome stability, at polycomb-enriched bivalent genes the same remodellers act in an opposite manner. These findings indicate that remodellers target specific nucleosomes at the edge of NFRs, where they regulate ES cell transcriptional programs.
- 27 January 2016
- Published by Springer Nature in Nature
- Vol. 530 (7588) , 113-116
Open AccessGenome-wide nucleosome specificity and function of chromatin remodellers in ES cells
Genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem (ES) cells are determined at single nucleosome resolution; each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller acts as a positive or negative regulator of transcription depending on the promoter chromatin organization and epigenetic marking of the gene it binds. The action of chromatin remodeling enzymes is required to allow transcription factors and the general transcription machinery access to DNA. Matthieu Gérard and colleagues determine genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem cells at single nucleosome resolution. They find that each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller can act as a positive or negative regulator of transcription depending on the activity of the gene it binds. The findings illustrate how remodellers work together at specific nucleosome positions adjacent to nucleosome-depleted promoter regions in order to regulate transcription. ATP-dependent chromatin remodellers allow access to DNA for transcription factors and the general transcription machinery, but whether mammalian chromatin remodellers1,2,3 target specific nucleosomes to regulate transcription is unclear. Here we present genome-wide remodeller–nucleosome interaction profiles for the chromatin remodellers Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind one or both full nucleosomes that flank micrococcal nuclease (MNase)-defined nucleosome-free promoter regions (NFRs), where they separate divergent transcription. Surprisingly, large CpG-rich NFRs that extend downstream of annotated transcriptional start sites are nevertheless bound by non-nucleosomal or subnucleosomal histone variants (H3.3 and H2A.Z) and marked by H3K4me3 and H3K27ac modifications. RNA polymerase II therefore navigates hundreds of base pairs of altered chromatin in the sense direction before encountering an MNase-resistant nucleosome at the 3′ end of the NFR. Transcriptome analysis after remodeller depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. Whereas at active genes individual remodellers have either positive or negative roles via altering nucleosome stability, at polycomb-enriched bivalent genes the same remodellers act in an opposite manner. These findings indicate that remodellers target specific nucleosomes at the edge of NFRs, where they regulate ES cell transcriptional programs.
- Open Access
- 31 October 2014
- Published by Springer Nature in Protocol Exchange
Tandem affinity purification of remodeler-mononucleosome complexes for ChIP-seq in mouse embryonic stem cells
- 31 October 2014
- Published by Springer Nature in Protocol Exchange
Open AccessTandem affinity purification of remodeler-mononucleosome complexes for ChIP-seq in mouse embryonic stem cells
- Open Access
- 22 December 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (12) , e15272
B-raf Alternative Splicing Is Dispensable for Development but Required for Learning and Memory Associated with the Hippocampus in the Adult Mouse
The B-raf proto-oncogene exerts essential functions during development and adulthood. It is required for various processes, such as placental development, postnatal nervous system myelination and adult learning and memory. The mouse B-raf gene encodes several isoforms resulting from alternative splicing of exons 8b and 9b located in the hinge region upstream of the kinase domain. These alternative sequences modulate the biochemical and biological properties of B-Raf proteins. To gain insight into the physiological importance of B-raf alternative splicing, we generated two conditional knockout mice of exons 8b and 9b. Homozygous animals with a constitutive deletion of either exon are healthy and fertile, and survive up to 18 months without any visible abnormalities, demonstrating that alternative splicing is not essential for embryonic development and brain myelination. However, behavioural analyses revealed that expression of exon 9b-containing isoforms is required for B-Raf function in hippocampal-dependent learning and memory. In contrast, mice mutated on exon 8b are not impaired in this function. Interestingly, our results suggest that exon 8b is present only in eutherians and its splicing is differentially regulated among species.
- 22 December 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (12) , e15272
Open AccessB-raf Alternative Splicing Is Dispensable for Development but Required for Learning and Memory Associated with the Hippocampus in the Adult Mouse
The B-raf proto-oncogene exerts essential functions during development and adulthood. It is required for various processes, such as placental development, postnatal nervous system myelination and adult learning and memory. The mouse B-raf gene encodes several isoforms resulting from alternative splicing of exons 8b and 9b located in the hinge region upstream of the kinase domain. These alternative sequences modulate the biochemical and biological properties of B-Raf proteins. To gain insight into the physiological importance of B-raf alternative splicing, we generated two conditional knockout mice of exons 8b and 9b. Homozygous animals with a constitutive deletion of either exon are healthy and fertile, and survive up to 18 months without any visible abnormalities, demonstrating that alternative splicing is not essential for embryonic development and brain myelination. However, behavioural analyses revealed that expression of exon 9b-containing isoforms is required for B-Raf function in hippocampal-dependent learning and memory. In contrast, mice mutated on exon 8b are not impaired in this function. Interestingly, our results suggest that exon 8b is present only in eutherians and its splicing is differentially regulated among species.
- 1 October 2010
- Published by Elsevier in Cellular Signalling
- Vol. 22 (10) , 1459-1468
Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway
- 1 October 2010
- Published by Elsevier in Cellular Signalling
- Vol. 22 (10) , 1459-1468
Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway
- Open Access
- 1 October 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (10) , 3663-3667
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation
Accumulating evidence points to inflammation as a promoter of carcinogenesis. MyD88 is an adaptor molecule in TLR and IL-1R signaling that was recently implicated in tumorigenesis through proinflammatory mechanisms. Here we have shown that MyD88 is also required in a cell-autonomous fashion for RAS-mediated carcinogenesis in mice in vivo and for MAPK activation and transformation in vitro. Mechanistically, MyD88 bound to the key MAPK, Erk, and prevented its inactivation by its phosphatase, MKP3, thereby amplifying the activation of the canonical RAS pathway. The relevance of this mechanism to human neoplasia was suggested by the finding that MyD88 was overexpressed and interacted with activated Erk in primary human cancer tissues. Collectively, these results show that in addition to its role in inflammation, MyD88 plays what we believe to be a crucial direct role in RAS signaling, cell-cycle control, and cell transformation.
- 1 October 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (10) , 3663-3667
Open AccessDual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation
Accumulating evidence points to inflammation as a promoter of carcinogenesis. MyD88 is an adaptor molecule in TLR and IL-1R signaling that was recently implicated in tumorigenesis through proinflammatory mechanisms. Here we have shown that MyD88 is also required in a cell-autonomous fashion for RAS-mediated carcinogenesis in mice in vivo and for MAPK activation and transformation in vitro. Mechanistically, MyD88 bound to the key MAPK, Erk, and prevented its inactivation by its phosphatase, MKP3, thereby amplifying the activation of the canonical RAS pathway. The relevance of this mechanism to human neoplasia was suggested by the finding that MyD88 was overexpressed and interacted with activated Erk in primary human cancer tissues. Collectively, these results show that in addition to its role in inflammation, MyD88 plays what we believe to be a crucial direct role in RAS signaling, cell-cycle control, and cell transformation.
- 1 April 2008
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 44 (4) , 623-632
Small GTP-binding proteins and their regulators in cardiac hypertrophy
- 1 April 2008
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 44 (4) , 623-632
Small GTP-binding proteins and their regulators in cardiac hypertrophy